| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
25,750,000 |
| Market
Cap: |
410.07(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.1 - $27.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 14.6 |
| Insider 6 Months : 15.4 |
| Insider 3/6 Months : 30.2 |
|
| Guru Rank Number : 140 |
| Guru Rank Value : 7.2 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Harrow Health engages in the development, production and sale of medications. Co. owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical businesses. Through its subsidiaries, Visionology, Inc., which provides an online eye health platform; Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
179,000 |
211,500 |
257,300 |
699,568 |
| Total Buy Value |
$1,948,031 |
$2,209,591 |
$2,938,957 |
$7,583,356 |
| Total People Bought |
2 |
2 |
3 |
3 |
| Total Buy Transactions |
7 |
9 |
13 |
15 |
| Total Shares Sold |
0 |
0 |
0 |
40,000 |
| Total Sell Value |
$0 |
$0 |
$0 |
$504,800 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Opaleye Management Inc. |
10% Owner |
– – • |
2021-08-18 |
4 |
B |
$8.64 |
$401,979 |
I/I |
46,500 |
147,500 |
1.5 |
1% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2021-08-17 |
4 |
B |
$8.57 |
$222,719 |
I/I |
26,000 |
146,000 |
1.5 |
2% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2021-07-21 |
4 |
B |
$7.60 |
$69,933 |
I/I |
9,206 |
145,000 |
1.5 |
36% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2021-07-20 |
4 |
B |
$7.20 |
$35,460 |
I/I |
4,925 |
140,294 |
1.5 |
40% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2021-07-19 |
4 |
B |
$6.97 |
$40,897 |
I/I |
5,869 |
140,169 |
1.5 |
49% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2021-06-18 |
4 |
B |
$8.35 |
$528,688 |
I/I |
63,322 |
140,000 |
1.5 |
16% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2021-06-17 |
4 |
B |
$8.32 |
$93,701 |
I/I |
11,262 |
136,478 |
1.5 |
15% |
|
| Lindstrom Richard L Md |
Director |
– • – |
2021-05-20 |
4 |
S |
$10.75 |
$107,500 |
I/I |
(10,000) |
90,000 |
|
9% |
|
| Baum Mark L |
Chief Executive Officer |
• • – |
2021-04-25 |
4 |
D |
$8.26 |
$2,759,906 |
D/D |
(334,129) |
1,353,547 |
|
- |
|
| Baum Mark L |
Chief Executive Officer |
• • – |
2021-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
850,000 |
1,687,676 |
|
- |
|
| Boll Andrew |
Chief Financial Officer |
• – – |
2021-04-25 |
4 |
D |
$8.26 |
$411,612 |
D/D |
(49,832) |
223,168 |
|
- |
|
| Boll Andrew |
Chief Financial Officer |
• – – |
2021-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
127,500 |
273,000 |
|
- |
|
| Baum Mark L |
Chief Executive Officer |
• • – |
2021-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
200,000 |
837,676 |
|
- |
|
| Boll Andrew |
Chief Financial Officer |
• – – |
2021-02-25 |
4 |
D |
$7.68 |
$57,600 |
D/D |
(7,500) |
145,500 |
|
- |
|
| Boll Andrew |
Chief Financial Officer |
• – – |
2021-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,000 |
153,000 |
|
- |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-12-22 |
4 |
B |
$5.19 |
$86,010 |
I/I |
16,557 |
136,016 |
1.5 |
44% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-12-21 |
4 |
B |
$5.24 |
$280,093 |
I/I |
53,459 |
135,359 |
1.5 |
48% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-12-18 |
4 |
B |
$5.31 |
$193,379 |
I/I |
36,400 |
133,300 |
1.5 |
46% |
|
| Principi Anthony |
Director |
– • – |
2020-09-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
93,798 |
93,798 |
|
- |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-07-12 |
4 |
B |
$4.98 |
$104,246 |
I/I |
20,900 |
131,900 |
1.5 |
28% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-07-11 |
4 |
B |
$4.96 |
$231,922 |
I/I |
46,800 |
2,808,100 |
1.5 |
28% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-07-10 |
4 |
B |
$4.98 |
$223,965 |
I/I |
45,000 |
2,761,300 |
1.5 |
28% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-07-09 |
4 |
B |
$4.82 |
$145,079 |
I/I |
30,000 |
130,000 |
1.5 |
37% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-07-08 |
4 |
B |
$4.99 |
$324,630 |
I/I |
65,000 |
2,691,300 |
1.5 |
39% |
|
| Opaleye Management Inc. |
10% Owner |
– – • |
2020-07-07 |
4 |
B |
$5.18 |
$213,996 |
I/I |
41,300 |
2,626,300 |
1.5 |
33% |
|
134 Records found
|
|
Page 3 of 6 |
|
|
0.31 (1.94%) 
